Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of adjuvant capecitabine
in patients who have undergone proximal pancreatico-duodenectomy.
Phase:
Phase 4
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust